<DOC>
	<DOCNO>NCT01170871</DOCNO>
	<brief_summary>The purpose study determine maximal tolerate dose ( MTD ) Ixabepilone Pemetrexed advance solid tumor obtain preliminary information regard activity combination . This research study research participant confirm metastatic unresectable solid tumor ( lung , breast , ovary , cervix , uterus , mesothelioma , prostate ) standard curative palliative measure exist longer effective .</brief_summary>
	<brief_title>Ixabepilone Pemetrexed/Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Epothilones</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>SWOG performance status 02 . Projected life expectancy least 3 month . Female male age 18 year . Provision inform consent prior studyrelated procedure . Female patient must pregnant due potential mutagenicity . teratogenicity treatment . A pregnancy test must administer 7 day prior administration therapy woman childbearing potential . Negative pregnancy test woman childbearing potential . Patients must agree use form contraception study initiation duration participation study . Sexually active male must also use reliable appropriate method contraception . Postmenopausal woman must amenorrheic least 12 month consider nonchildbearing potential . Patients must recover acute toxicity previous surgery , chemotherapy radiation therapy . Adequate organ function define : ANC &gt; 1500/mm3 Platelet count &gt; 100,000 cells/mm3 Hemoglobin &gt; 9.0g/dL Serum creatinine &lt; 1.5 mg/dl creatinine clearance &gt; 45 mL/minute ( calculate CockcroftGault formula . ) Hepatic function : Patients must adequate liver function : AST ALT &lt; 2.5 X upper limit normal ( ULN ) , alkaline phosphatase &lt; 2.5 X upper limit normal . In patient bone metastasis evidence liver metastasis bilirubin &lt; upper limit normal alkaline phosphatase &lt; 5 ULN allow Serum Bilirubin &lt; 1.5 mg/dL Peripheral neuropathy grade 01 . No concomitant therapy direct cancer allow . The ability interrupt NSAIDS 2 day ( 5 day longacting NSAIDs ) , day , 2 day follow administration pemetrexed . The ability take folic acid , Vitamin B12 , dexamethasone accord protocol . Laboratory result : Serum bilirubin &gt; 1.5 upper limit reference range ( ULRR ) Serum creatinine &gt; 1.5 x ULRR creatinine clearance &lt; 45 mL/minute ( calculate CockcroftGault formula ) Women currently pregnant breast feeding . Receipt investigational agent within 30 day prior commence study treatment . Last dose prior chemotherapy discontinue less 4 week start study therapy . Last radiation therapy within last 4 week start study therapy , except palliative radiotherapy . Prior radiation must include ≥ 30 % major bone marrow contain area ( pelvis , lumbar spine ) . Any unresolved toxicity great CTC grade 1 previous anti cancer therapy , exclude alopecia . CTC Grade 1 great neuropathy ( motor sensory ) study entry . Hematologic function absolute neutrophil ≤ 1500/mm3 and/or platelet &lt; 100,000/mm 3 . Hepatic function serum bilirubin great upper institutional limit normal , ALT AST &gt; 2.5 time upper institutional limit normal . Presence third space fluid control drainage .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>